In a move that was not unexpected, the FDA has given Chantix, a popular smoking cessation drug, a black box warning; the strongest warning level a drug can get. This black box warning concerns adverse neuropsychiatric symptoms brought on by the use of varenicline (Chantix), most commonly in those with a previous psychiatric disorder. Surprisingly the anti-depressant Welbutrin (commonly used as a smoking cessation drug) also received the mandate for a black box warning. This was a little more surprising but nonetheless I think a good move to clue those in who don’t know this possible interaction.
Back in my younger days when I knew much less about drugs and their side effects I had a friend (we’ll call him Charles for anonymity’s sake) who suffered through a manic episode brought on by Chantix use. He was a 25 year old male with bipolar disorder II (BP) who was on the mood stabilizer Seroquel and a minimal dose of Zoloft. As with most people diagnosed with a personality disorder he was an avid smoker and upon hearing about the success people were having with Chantix (it really is effective to help people stop smoking) decided to ask his psychiatrist if using it was an option.
There were already warnings against prescribing Chantix to those with previous psychiatric problems, specifically those with suicidal thoughts or being previously diagnosed with BP or schizophrenia. Although Charles did bring his concerns to the table (he is constantly hypomanic and was afraid of the induced mania he had read about) the decision was to begin the treatment. After one week he suffered a tremendous manic episode and managed to piss off everyone within a 20ft radius as well as mangle some good personal relationships. Luckily he did not have to be hospitalized, but (more…)